CORONA Remedies balance sheet

As of Mar 2026

Total assets: ₹1,205cr
Shareholders' equity: ₹747cr
Total debt: ₹143cr
Cash and investments: ₹1.8cr

₹ crore except per share

Tap a line for its trend	FY26Mar 2026

Non-current assets
	291
	143
	263
	26.1
	0.2
	0.0
	130
	130
	3.6
	857
Current assets
	125
	146
	1.8
	42.3
	0.3
	0.3
	190
	33.1
	348
	1,205
Equity
	61.2
	686
	747
	747
Liabilities
	18.9
	18.9
	66.1
	12.2
	97.1
	143
	147
	22.8
	313
	33.0
	8.4
	7.0
	361
	458
	1,205
Trade payables — MSME split
	9.9
	137

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

CORONA₹2,200.60

CORONA Remedies Ltd.

· Pharma & Health

₹ CrorePeersERIS MANKIND APLLTD ALIVUS AKUMS AGARWALEYE HCG ADVENZYMESMcap ₹13,459 Cr

View

In ₹ Crore except Per Share As of	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	291.1	291.1
+ Capital Work-in-Progress	143.1	143.1
+ Other Intangibles	262.8	262.8
+ Investments (Equity Method)	26.1	26.1
+ Non-current Investments	0.2	0.2
+ Long-term Loans	0.0	0.0
+ Other Non-current Financial Assets	129.9	129.9
Non-current Financial Assets	130.1	130.1
+ Other Non-current Assets	3.6	3.6
Total Non-current Assets	856.8	856.8
Current Assets
+ Inventories	125.0	125.0
+ Trade Receivables	145.6	145.6
+ Cash & Cash Equivalents	1.8	1.8
+ Other Bank Balances	42.3	42.3
+ Short-term Loans	0.3	0.3
+ Other Current Financial Assets	0.3	0.3
Current Financial Assets	190.2	190.2
+ Other Current Assets	33.1	33.1
Total Current Assets	348.3	348.3
Total Assets	1,205.1	1,205.1
Equity
+ Equity Share Capital	61.2	61.2
+ Other Equity / Reserves	685.7	685.7
Equity — Owners of Parent	746.9	746.9
Total Equity	746.9	746.9
Liabilities
+ Other Non-current Financial Liab	18.9	18.9
Non-current Financial Liabilities	18.9	18.9
+ Provisions — Non-current	66.1	66.1
+ Deferred Tax Liabilities	12.2	12.2
Non-current Liabilities	97.1	97.1
+ Borrowings — Current	142.9	142.9
+ Trade Payables	147.1	147.1
+ Other Current Financial Liab	22.8	22.8
Current Financial Liabilities	312.8	312.8
+ Provisions — Current	33.0	33.0
+ Current Tax Liabilities	8.4	8.4
+ Other Current Liabilities	7.0	7.0
Current Liabilities	361.2	361.2
Total Liabilities	458.3	458.3
Total Equity & Liabilities	1,205.1	1,205.1
Trade Payables — MSME split
+ Dues to Micro & Small — Current	9.9	9.9
+ Dues to Other Creditors — Current	137.2	137.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.